BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 7686031)

  • 41. Differential expression of colony-stimulating factor (CSF) in murine macrophage clones: interferon-gamma-mediated inhibition of CSF production.
    Ogawa Y; Ohno N; Kameoka K; Yabe S; Sudo T
    Cell Struct Funct; 1994 Feb; 19(1):49-56. PubMed ID: 7520841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
    Masucci G; Wersäll P; Ragnhammar P; Mellstedt H
    Cancer Immunol Immunother; 1989; 29(4):288-92. PubMed ID: 2665935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor.
    Mochida-Nishimura K; Akagawa KS; Rich EA
    Cell Immunol; 2001 Nov; 214(1):81-8. PubMed ID: 11902832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
    Connor RI; Shen L; Fanger MW
    J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.
    Vadas MA; Nicola NA; Metcalf D
    J Immunol; 1983 Feb; 130(2):795-9. PubMed ID: 6600255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells.
    Fabian I; Baldwin GC; Golde DW
    Leukemia; 1987 Aug; 1(8):613-7. PubMed ID: 3312847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
    Wang M; Friedman H; Djeu JY
    J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
    Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
    Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.
    Suzu S; Yanai N; Saito M; Kawashima T; Kasahara T; Saito M; Takaku F; Motoyoshi K
    Jpn J Cancer Res; 1990 Jan; 81(1):79-84. PubMed ID: 2108950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
    Munn DH; Cheung NK
    J Exp Med; 1990 Jul; 172(1):231-7. PubMed ID: 2193096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
    Ozkaynak MF; Sondel PM; Krailo MD; Gan J; Javorsky B; Reisfeld RA; Matthay KK; Reaman GH; Seeger RC
    J Clin Oncol; 2000 Dec; 18(24):4077-85. PubMed ID: 11118469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.
    Lopez AF; Eglinton JM; Gillis D; Park LS; Clark S; Vadas MA
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7022-6. PubMed ID: 2550928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
    Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
    Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A; Carlino JA
    J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of granulocyte and granulocyte-macrophage colony-stimulating factors from human monocytes stimulated by Fc fragments of human IgG.
    Ishiguro A; Nakahata T; Koike K; Yoshida H; Shimbo T; Komiyama A
    Br J Haematol; 1991 Sep; 79(1):14-21. PubMed ID: 1716961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils.
    Buckle AM; Jayaram Y; Hogg N
    Clin Exp Immunol; 1990 Aug; 81(2):339-45. PubMed ID: 2117512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.
    Schaafsma MR; Falkenburg JH; Landegent JE; Duinkerken N; Osanto S; Ralph P; Kaushansky K; Wagemaker G; Van Damme J; Willemze R
    Blood; 1991 Oct; 78(8):1981-7. PubMed ID: 1912580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.